Literature DB >> 7969820

The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels.

E M Briley1, S J Lolait, J Axelrod, C C Felder.   

Abstract

Arginine vasopressin mediates its effects through vasopressin receptor activation and second messenger production. Recent cloning of the V1a receptor provided the opportunity to investigate the possible signal transduction pathways associated with this single vasopressin receptor subtype. When stably expressed in CHO cells, vasopressin stimulated several signal transduction pathways simultaneously including calcium influx, phospholipase A2, phospholipase C, and phospholipase D. Vasopressin-stimulated release of arachidonic acid, IP3 formation, and phosphatidylethanol formation (in the presence of 1% ethanol) were used as indexes of phospholipase A2, phospholipase C, and phospholipase D activation, respectively. V1a receptor-activation stimulated a peak followed by a sustained plateau phase of intracellular calcium. The plateau phase was dependent on extracellular calcium, insensitive to blockers of voltage sensitive calcium channels, blocked by heavy metals, and quenched when MnCl2 was present in the extracellular media. Removal of extracellular calcium blunted the release of IP3, and blocked the release of arachidonic acid and phosphatidylethanol indicating that these responses were at least in part regulated by receptor-operated calcium influx. Vasopressin-stimulated release of arachidonic acid and phosphatidylethanol were augmented with the phorbol ester PMA, and this augmentation was blocked by inhibitors of protein kinase C and absent with long-term PMA treatment. Vasopressin-stimulated IP3 release was inhibited with PMA and the inhibition reversed with protein kinase C inhibitors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969820     DOI: 10.1016/0143-4179(94)90017-5

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  11 in total

1.  Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease.

Authors:  R M Nitsch; C Kim; J H Growdon
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Extrapituitary expression of the rat V1b vasopressin receptor gene.

Authors:  S J Lolait; A M O'Carroll; L C Mahan; C C Felder; D C Button; W S Young; E Mezey; M J Brownstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

3.  Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells.

Authors:  Torsten Giesecke; Nina Himmerkus; Jens Leipziger; Markus Bleich; Taka-Aki Koshimizu; Michael Fähling; Alina Smorodchenko; Julia Shpak; Carolin Knappe; Julian Isermann; Niklas Ayasse; Katsumasa Kawahara; Jan Schmoranzer; Niclas Gimber; Alexander Paliege; Sebastian Bachmann; Kerim Mutig
Journal:  J Am Soc Nephrol       Date:  2019-05-16       Impact factor: 10.121

4.  Pituitary corticotroph identity and receptor-mediated signaling: a transcriptomics perspective.

Authors:  Stanko S Stojilkovic; Rafael M Previde; Arthur S Sherman; Patrick A Fletcher
Journal:  Curr Opin Endocr Metab Res       Date:  2022-06-09

5.  A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells.

Authors:  Dandan Dou; Yuge Ji; Junjie Zheng; Jingxin Li; Xiaolong Zhu; Shuhai Tang; Hongjuan Wang; Qin Li; Haiyan Jing
Journal:  Dig Dis Sci       Date:  2021-11-09       Impact factor: 3.487

6.  Activation of multiple intracellular transduction signals by vasopressin in vasopressin-sensitive neurones of the rat supraoptic nucleus.

Authors:  N Sabatier; P Richard; G Dayanithi
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

7.  Vasopressin receptors V1a and V2 are not osmosensors.

Authors:  Kasper Lykke; Mette Assentoft; Robert A Fenton; Mette M Rosenkilde; Nanna MacAulay
Journal:  Physiol Rep       Date:  2015-08

8.  Antagonists of the Vasopressin V1 Receptor and of the β(1)-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes - but the Mechanisms Differ.

Authors:  Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du; Leif Hertz; Junnan Xu; Ye Chen; Marie E Gibbs; Ting Du
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

Review 9.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

10.  The Modulatory Effect of Ischemia and Reperfusion on Arginine Vasopressin-Induced Arterial Reactions.

Authors:  Katarzyna Szadujkis-Szadurska; Bartosz Malinowski; Małgorzata Piotrowska; Grzegorz Grześk; Michał Wiciński; Marta Gajdus
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.